Advancing vaccine research in Africa: A comprehensive analysis of vaccine clinical trials landscape
Contemporary Clinical Trials · 2025
DOI: 10.1016/j.cct.2024.107779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2025. Verfasst von Lindi Mathebula und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cochrane South Africa, South African Medical Research Council, Tygerberg 7505, South Africa. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Biomedical Research. Die Arbeit nennt 32 Literaturangaben. Gefördert von: World Health Organization, South African Medical Research Council, Global Fund to Fight AIDS, Tuberculosis and Malaria.
Abstract (Originalsprache)
This study presents an in-depth analysis of vaccine clinical trials in Africa, emphasising the significance of local investments to address the continent's healthcare requirements. The research scrutinises vaccine trials across various African nations, focusing on trial distribution, phases, funding sources, recruitment sites, recruitment statuses, and age group participation. The findings suggest substantial trial activity in countries like Kenya, Ghana, and Gambia, whereas nations like the Democratic Republic of the Congo and Tunisia exhibit minimal representation. Notably, COVID-19, HIV, and Yellow Fever vaccines prominently feature in the trials, with Phase 3 trials being the most prevalent. The presence of "Not Applicable" trials indicates adopting adaptive trial designs. Analysis of funding patterns reveals substantial international and local support, reflecting an escalating commitment to vaccine research in Africa. Nevertheless, concerns persist regarding disparities in trial distribution and age group participation, underscoring the necessity for robust regulatory frameworks and augmented local R&D capacity. Addressing these disparities can enhance the efficacy of vaccine research and elevate health outcomes across the African continent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cochrane South Africa, South African Medical Research Council, Tygerberg 7505, South Africa.
- Vaccine-Preventable Diseases Program, World Health Organization Regional Office for Africa, Brazzaville, P.O. Box 06, Congo.
- Cochrane South Africa, South African Medical Research Council, Tygerberg 7505, South Africa. Electronic address: dndwandwe@mrc.ac.za.
Förderung
- World Health Organization
- South African Medical Research Council
- Global Fund to Fight AIDS, Tuberculosis and Malaria
- Centers for Disease Control and Prevention
- Bill and Melinda Gates Foundation
Zitieren
APA
Mathebula, L., Malinga, T., Iwu-Jaja, C., & Ndwandwe, D. (2025). Advancing vaccine research in Africa: A comprehensive analysis of vaccine clinical trials landscape. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107779
Vancouver
Mathebula L, Malinga T, Iwu-Jaja C, Ndwandwe D. Advancing vaccine research in Africa: A comprehensive analysis of vaccine clinical trials landscape. Contemporary Clinical Trials. 2025. doi:10.1016/j.cct.2024.107779
BibTeX
@article{Mathebula2025,
author = {Mathebula, Lindi and Malinga, Thobile and Iwu-Jaja, Chinwe and Ndwandwe, Duduzile},
title = {Advancing vaccine research in Africa: A comprehensive analysis of vaccine clinical trials landscape},
journal = {Contemporary Clinical Trials},
year = {2025},
doi = {10.1016/j.cct.2024.107779}
}
EUVIMED